Company-operated same-restaurant sales increase 2.0% in quarter; two-year same-restaurant sales increase 5.2% Company reaffirms 2014 Adjusted EPS outlook; now expects Adjusted EBITDA of approximately $390 million; reiterates long-term outlook
Company opens 600th systemwide Image Activation restaurant Company realigning, reinvesting resources to focus on restaurant growth and technology; expects to achieve total G&A expense savings of approximately $30 million Board of Directors authorizes 10 percent increase in quarterly dividend rate DUBLIN, Ohio , Nov.
SOUTH SAN FRANCISCO, CA --
Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has
priced its previously announced offering of $800,000,000 aggregate
principal amount of 3.300% senior notes due 2022 at an issue price of
99.991% of the principal amount.
Journalists and other readers are advised that the news release, TheStreet Reports Third Quarter 2014 Results, issued 06-Nov-2014 by TheStreet, Inc. over PR Newswire, has been updated with the inclusion of financial tables.
Revenue increased 14.0% over prior year quarter, in constant currency
Upper extremity constant currency revenue growth of 20.0% led by Aequalis Ascend Flex
Entered into definitive merger agreement with Wright Medical Group on October 27 to create premier high-growth extremities-biologics company
AMSTERDAM, The Netherlands, Nov.
Town Sports International Holdings, Inc. ("TSI" or the "Company")
(NASDAQ:CLUB) today announced that it will hold its quarterly conference
call to discuss third quarter 2014 financial results on Tuesday,
November 11, 2014 at 8:30 a.m. Eastern Time.
TransAct Technologies Incorporated (Nasdaq:TACT) (“TransAct” or the
“Company”) today reported operating results for the third quarter ended
September 30, 2014, as summarized below:
Bart Shuldman, Chairman and Chief Executive Officer of TransAct,
commented, “As anticipated, the third quarter results reflect lower
overall contributions from casino and gaming operations as a result of
ongoing challenges in the gaming industry.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.